Cargando…
Delivery of mRNA Vaccine against SARS-CoV-2 Using a Polyglucin:Spermidine Conjugate
One of the key stages in the development of mRNA vaccines is their delivery. Along with liposome, other materials are being developed for mRNA delivery that can ensure both the safety and effectiveness of the vaccine, and also facilitate its storage and transportation. In this study, we investigated...
Autores principales: | Karpenko, Larisa I., Rudometov, Andrey P., Sharabrin, Sergei V., Shcherbakov, Dmitry N., Borgoyakova, Mariya B., Bazhan, Sergei I., Volosnikova, Ekaterina A., Rudometova, Nadezhda B., Orlova, Lyubov A., Pyshnaya, Inna A., Zaitsev, Boris N., Volkova, Natalya V., Azaev, Mamedyar Sh., Zaykovskaya, Anna V., Pyankov, Oleg V., Ilyichev, Alexander A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910849/ https://www.ncbi.nlm.nih.gov/pubmed/33494530 http://dx.doi.org/10.3390/vaccines9020076 |
Ejemplares similares
-
SARS-CoV-2 RBD Conjugated to Polyglucin, Spermidine, and dsRNA Elicits a Strong Immune Response in Mice
por: Volosnikova, Ekaterina A., et al.
Publicado: (2023) -
Immunogenicity of the DNA/Protein Combined Vaccine against COVID-19
por: Borgoyakova, M. B., et al.
Publicado: (2023) -
Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice
por: Borgoyakova, Mariya B., et al.
Publicado: (2022) -
Construction and Immunogenicity of Modified mRNA-Vaccine Variants Encoding Influenza Virus Antigens
por: Starostina, Ekaterina V., et al.
Publicado: (2021) -
Optimization of In Vivo Electroporation Conditions and Delivery of DNA Vaccine Encoding SARS-CoV-2 RBD Using the Determined Protocol
por: Kisakov, Denis Nikolaevich, et al.
Publicado: (2022)